Roche and Life Technologies sign PCR licencing agreement

Roche and Life Technologies Corporation have announced that they have entered into two license agreements to allow LTC to expand its PCR offerings for diagnostics applications. Under the agreements, Roche has granted LTC an in vitro diagnostics product license to all of Roche’s patents for real-time PCR as well as other PCR-related technology in the diagnostics field. Also covered in these agreements are reagents and methods of using SYBR Green I technology, melting curve analysis for real-time PCR, and rights to use high-resolution melting-curve analysis technology in the diagnostics field. Financial terms of the settlement were not disclosed.